Neurogene (NGNE) Shares Outstanding (2013 - 2026)

Neurogene has reported Shares Outstanding for 14 years, with the latest figure at $15.6 million in Q1 2026.

• For the quarter ending Q1 2026, Shares Outstanding rose 4.6% year-over-year to $15.6 million; the trailing twelve-month figure through Mar 2026 stood at $15.6 million (up 4.6% YoY), and the FY2025 full-year result was $15.5 million, up 4.28% from the prior year.
• Shares Outstanding for Q1 2026 stood at $15.6 million, up from $15.5 million in the prior quarter.
• The five-year high for Shares Outstanding was $15.6 million in Q1 2026, with the low at $428334.0 in Q4 2022.
• Historically, Shares Outstanding has averaged $11.6 million across 5 years, with a median of $12.9 million in 2024.
• The largest YoY upside for Shares Outstanding was 2893.85% in 2023 against a maximum downside of 94.78% in 2023.
• Neurogene's Shares Outstanding stood at $428334.0 in 2022, then jumped by 2893.85% to $12.8 million in 2023, then advanced by 15.84% to $14.9 million in 2024, then climbed by 4.28% to $15.5 million in 2025, then rose by 0.81% to $15.6 million in 2026.
• The last three Shares Outstanding figures came in at $15.6 million (Q1 2026), $15.5 million (Q4 2025), and $14.8 million (Q3 2025), per Business Quant data.